Andrew Quick - May 18, 2021 Form 4 Insider Report for AVITA Medical, Inc. (RCEL)

Signature
/s/ Donna Shiroma, by power of attorney
Stock symbol
RCEL
Transactions as of
May 18, 2021
Transactions value $
$0
Form type
4
Date filed
9/7/2021, 04:05 PM
Next filing
Jul 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCEL Common Stock Award +10.5K 10.5K Jul 6, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCEL Stock Options (Right to Buy) Award $0 +4.04K +25% $0.00 20.2K May 18, 2021 Common Stock 4.04K $6.32 Direct F2
transaction RCEL Stock Options (Right to Buy) Award $0 +6.93K $0.00 6.93K Jul 6, 2021 Common Stock 6.93K $20.21 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-vesting criteria with respect to the particular portion of Restricted Stock Units.
F2 These Stock Options were originally granted on May 18, 2017 and vested on May 18, 2021, upon the satisfaction of a performance-based vesting condition.
F3 These Stock Options vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of such Stock Options.